House Democrats Aim to Broaden FDA’s Foreign Powers

Given increasing concerns with the quality and integrity of drug products manufactured overseas, a group of Democratic congressmen is floating a draft of a bill that would give the FDA broader powers and bring the agency’s inspections of foreign plants in line with U.S.-based ones. The discussion draft was released late Monday to “equip the FDA with the authorities and funding it needs to regulate what is now a global marketplace for drugs.”
Drug Industry Daily